Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIFE-MET Study: Lifestyle intervention and Metformin in early puberty
2024-511009-50-00Phase 2Authorised
- Sponsor
- Herlev Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in precocious puberty and Overweight comparing Metformin plus lifestyle intervention with Placebo plus lifestyle intervention (2 arms). Primary endpoint: Change in bone age over 1 year. Planned start Apr 2024; status: authorised.
02
Drugs
metformin
03
Conditions
precocious pubertyOverweight
Beyond the preview
Go deeper on 2024-511009-50-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511009-50-00.